NCT03044080 is a Phase 4 clinical trial of IncobotulinumtoxinA in Stroke Rehabilitation, sponsored by Parc de Salut Mar.

Who is sponsoring NCT03044080?

NCT03044080 is sponsored by Parc de Salut Mar.

What drugs are being tested in NCT03044080?

Interventions in NCT03044080: IncobotulinumtoxinA, OnabotulinumtoxinA.

What condition does NCT03044080 study?

NCT03044080 studies Stroke Rehabilitation, Stroke Rehabilitation Spasticity Management.

Is NCT03044080 still recruiting?

NCT03044080 is currently completed. Last updated 20 October 2017.

Last reviewed 2017-10-20 · How we verify

NCT03044080

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Botulinum Neurotoxin Type A (BoNT/A) Free of Complexing Proteins in the Spastic Equinovarus Foot

Completed Phase 4 Last updated 20 October 2017

What this trial tests

Phase 4 trial testing IncobotulinumtoxinA in Stroke Rehabilitation in 20 participants. Completed in 30 September 2017.

Timeline

1 January 2015

Primary endpoint
30 June 2017

30 September 2017

Quick facts

Lead sponsor	Parc de Salut Mar
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	20
Start date	1 January 2015
Primary completion	30 June 2017
Estimated completion	30 September 2017
Sites	1 location across Spain

Drugs / interventions tested

IncobotulinumtoxinA (INCOBOTULINUMTOXINA) — full drug profile →
OnabotulinumtoxinA (ONABOTULINUMTOXINA) — full drug profile →

Conditions studied

Stroke Rehabilitation — all drugs for Stroke Rehabilitation →
Stroke Rehabilitation Spasticity Management — all drugs for Stroke Rehabilitation Spasticity Management →

Sponsor

Parc de Salut Mar — full company profile →

Who can join

Adults 18 to 80, any sex, with Stroke Rehabilitation or Stroke Rehabilitation Spasticity Management. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Clinical randomized clinical trial to assess the effectiveness on walking speed of repeated use of botulinum neurotoxin type A (BoNT/A)in the post-stroke spastic equinovarus foot in three successive infiltrations at 6-month intervals, checking if the sustainability of the effect is greater in incobotulinumtoxin A (Xeomin®) than in onabotulinumtoxinA (Botox®).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of IncobotulinumtoxinA

Trials testing the same drug.

NCT06604832 — Effects of Microtox on Facial Skin Quality, Fine Wrinkles, and Texture · Phase 1 · completed
NCT06091020 — A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participant · Phase 2 · completed
NCT05222607 — Longitudinal Evaluation and Real-world Evidence of NT201 · terminated
NCT05585398 — A Study to Evaluate the Distribution of Botulinum Neurotoxin Type A Administered as Intradermal Injections, Comparing Di · Phase 1 · completed
NCT04290169 — Effect of Video Game-assisted and BoNT-A Injection Therapy on Spasticity, Activity and Participation in CP Patients · NA · unknown

Other recruiting trials for Stroke Rehabilitation

Currently open trials in the same condition.

NCT07228754 — How Realistic Are Caregivers' Expectations in Patients With Subacute Stroke? · recruiting
NCT06998485 — Substrates for Post-Stroke Arm Rehabilitation · NA · recruiting
NCT07229053 — Hospitalisation Duration in Stroke Patients · recruiting
NCT06965894 — Lower Extremity Pressure Splints in HP · NA · recruiting
NCT06898073 — Dual-task Training During Curved Walking in Stroke Patients · NA · recruiting

Other Parc de Salut Mar trials

Trials by the same sponsor.

NCT06163235 — Efficacy of a Mobile Application and Semi-attendance Program in Bariatric Surgery · NA · not yet recruiting
NCT07223450 — A Study on Oral and Intranasal Forms of Oxycodone in Healthy Volunteers Using Pharmacokinetic Modeling · Phase 1 · completed
NCT07504913 — Spanish Validation of KOQUSS-40 Questionnaire: Assessing QoL of Gastric Cancer Patients After Gastrectomy: SPQUSS-41 · recruiting
NCT06806072 — BALNEOTHERAPY FOR BREAST CANCER PATIENTS UNDERGOING ENDOCRINE THERAPY · NA · not yet recruiting
NCT04084795 — Augmentation of EMDR With tDCS in the Treatment of Fibromyalgia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03044080 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Parc de Salut Mar
Last refreshed: 20 October 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03044080.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing